Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson’s disease: a two-cohort case-control study
Hongxu Pan, Yuwen Zhao, Junpu Mei, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 118
An atlas of transcriptionally defined cell populations in the rat ventral tegmental area
Robert A. Phillips, Jennifer J. Tuscher, Samantha L. Black, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110616-110616
Open Access | Times Cited: 91
Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
Yumin Wang, Shuang Wu, Qiang Li, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 81
Pesticides and Parkinson’s disease: Current and future perspective
Md Shahidul Islam, Fazli Azim, Hedaeytullah Saju, et al.
Journal of Chemical Neuroanatomy (2021) Vol. 115, pp. 101966-101966
Closed Access | Times Cited: 64
A proteogenomic view of Parkinson’s disease causality and heterogeneity
Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 47
Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease
Léon-Charles Tranchevent, Rashi Halder, Enrico Glaab
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 17
The Chinese Parkinson's Disease Registry (CPDR): Study Design and Baseline Patient Characteristics
Xiaoxia Zhou, Zhenhua Liu, Xiaoting Zhou, et al.
Movement Disorders (2022) Vol. 37, Iss. 7, pp. 1335-1345
Closed Access | Times Cited: 23
Molecular mechanism of zinc neurotoxicity in Alzheimer’s disease
Siju Ellickal Narayanan, Nisha Abdul Rehuman, Seetha Harilal, et al.
Environmental Science and Pollution Research (2020) Vol. 27, Iss. 35, pp. 43542-43552
Closed Access | Times Cited: 38
The potential of biomaterials for central nervous system cellular repair
Sarah Jarrin, Sílvia Cabré, Eilís Dowd
Neurochemistry International (2021) Vol. 144, pp. 104971-104971
Open Access | Times Cited: 28
The mutation spectrum of Parkinson‐disease‐related genes in early‐onset Parkinson's disease in ethnic Chinese
Yongping Chen, Shihui Yu, Guohui Zhang, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3218-3228
Closed Access | Times Cited: 20
A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
Johannes Burtscher, Vittorio Maglione, Alba Di Pardo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 582-582
Open Access | Times Cited: 27
Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease
Xingxing Jian, Guihu Zhao, He Chen, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5218-5225
Open Access | Times Cited: 18
GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis
Hannah Larbalestier, Marcus Keatinge, Lisa Watson, et al.
Journal of Neuroscience (2021) Vol. 42, Iss. 4, pp. 702-716
Open Access | Times Cited: 23
Luteolin Suppresses Microglia Neuroinflammatory Responses and Relieves Inflammation-Induced Cognitive Impairments
Wei Zhou, Mengmeng Hu, Jingrong Hu, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1800-1811
Closed Access | Times Cited: 22
Genetic Analysis of Six Transmembrane Protein Family Genes in Parkinson’s Disease in a Large Chinese Cohort
Yuwen Zhao, Kailin Zhang, Hongxu Pan, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 15
Biomaterials in the treatment of Parkinson's disease
Uma Maheswari Krishnan
Neurochemistry International (2021) Vol. 145, pp. 105003-105003
Closed Access | Times Cited: 18
Fatal attraction – The role of hypoxia when alpha-synuclein gets intimate with mitochondria
Johannes Burtscher, Muhammed Muazzam Kamil Syed, Markus A. Keller, et al.
Neurobiology of Aging (2021) Vol. 107, pp. 128-141
Open Access | Times Cited: 18
The Association Between Lysosomal Storage Disorder Genes and Parkinson’s Disease: A Large Cohort Study in Chinese Mainland Population
Yuwen Zhao, Hongxu Pan, Zhenhua Liu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 18
Design, synthesis, and biological evaluation of novel indanone-based hybrids as multifunctional cholinesterase inhibitors for Alzheimer's disease
Mohammad Shahrivar‐Gargari, Maryam Hamzeh‐Mivehroud, Salar Hemmati, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129787-129787
Closed Access | Times Cited: 18
β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease
Shilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology (2021) Vol. 895, pp. 173877-173877
Closed Access | Times Cited: 15
Parkinson’s disease-associated genetic variants synergistically shape brain networks
Zhichun Chen, Bin Wu, Guanglu Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
Kenya Nishioka, Yuzuru Imai, Hiroyo Yoshino, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
Ju Wang, Hui‐Jie Hu, Zikai Liu, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Genetic analysis of dystonia-related genes in Parkinson's disease
Yige Wang, Yuwen Zhao, Hongxu Pan, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top